Development of a novel form of an oral 5-FU derivative (TS-1) directed to the potentiation of the tumor selective cytotoxicity of 5-FU by two biochemical modulators

Anti-Cancer Drugs 1996, 7, pp. 548-557
Tetsuhiko Shirasaka, Yuji Shimamato, Hideyuki Ohshimo, Masahiro Yamaguchi, Toshiyuki Kato, Kazuhiko Yonekura and Masakazu Fukushima
저작권자 © 의학신문 무단전재 및 재배포 금지